NSC60256

dc.creatorUS National Cancer Institute
dc.date2005-08-23T12:41:46Z
dc.date2005-08-23T12:41:46Z
dc.date2003-02-01
dc.date2005-08-23T12:41:46Z
dc.date.accessioned2026-08-03T02:56:37Z
dc.format3883 bytes
dc.format4120 bytes
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.identifierNSC60256
dc.identifierhttp://www.dspace.cam.ac.uk/handle/1810/56900
dc.identifierYRZQHIVOIFJEEE-UHFFFAOYSA-N
dc.identifierInChI=1S/C9H8ClN5/c10-6-1-3-7(4-2-6)14-9-13-5-12-8(11)15-9/h1-5H,(H3,11,12,13,14,15)
dc.identifierC9H8ClN5,10-6-1H-3H-7(4H-2H-6)15H-9-13-5H-12-8(11H2)14-9
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/170913
dc.languageen_GB
dc.publisherUnilever Center for Molecular Informatics, Cambridge University
dc.titleNSC60256
dc.titles-Triazine, 2-amino-4-(p-chloroanilino)-, monohydrochloride (8CI)
dc.titleOrpidan
dc.title1,3,5-Triazine-2,4-diamine, N-(4-chlorophenyl)-, monohydrochloride (9CI)
dc.typeChemical Structures

Files